Stock listing
NASDAQ:ACGN Aceragen Inc. Stock
Follow Aceragen Inc. into a list and get an email when it puts out news.
Delisted NASDAQ:ACGN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:ACGN
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Mark Alan Goldberg Other companies: Blueprint Medicines Corp (Director · Since at least Jun 25, 2015); Audentes Therapeutics Inc (Director · Dec 11, 2017 – Jan 15, 2020 · Past); aTyr Pharma, Inc. (Director · May 6, 2015 – May 9, 2017 · Past); Crescent Biopharma, Inc. (Director · Jul 8, 2014 – May 1, 2024 · Past); ImmunoGen Inc (Director · Nov 8, 2011 – Feb 12, 2024 · Past); Synageva BioPharma Corp (EVP, Medical & Reg. Strategy · Nov 2, 2011 – Sep 19, 2014 · Past) | Director · Jan 7, 2014 – Jun 23, 2022 · Past |
| Carol A. Schafer Other companies: Immunome, Inc. (Director · Since at least Jan 2, 2024); Kura Oncology, Inc. (Director · Since at least Jun 3, 2021); Repare Therapeutics Inc (Director · Since at least May 13, 2021); Insmed Incorporated (Director · Since at least May 12, 2021); Five Prime Therapeutics Inc (Director · Apr 16, 2021 – Apr 16, 2021 · Past) | Director · Oct 1, 2020 – Jun 23, 2022 · Past |
| James Geraghty Other companies: Fulcrum Therapeutics, Inc. (Board Member · Since at least Jul 17, 2019); Voyager Therapeutics, Inc. (Director · Since at least Jun 15, 2016); Orchard Therapeutics PLC (Director · Jan 1, 2020 – Jan 24, 2024 · Past); Palvella Therapeutics, Inc. (Director · May 22, 2017 – Dec 12, 2024 · Past); Juniper Pharmaceuticals Inc (Director · Aug 2, 2016 – Aug 14, 2018 · Past) | Director · May 13, 2016 – Jun 23, 2022 · Past |
| Vincent Milano Other companies: BioCryst Pharmaceuticals, Inc. (Director · Since at least Jul 26, 2021); Aclaris Therapeutics, Inc. (Director · Since at least Jan 7, 2020); Spark Therapeutics Inc (Director · Jan 29, 2015 – Dec 17, 2019 · Past); Viropharma Inc (President and CEO, Director · Jun 7, 2010 – Jan 24, 2014 · Past); Vanda Pharmaceuticals Inc. (Director · Apr 21, 2010 – Jun 13, 2018 · Past) | Director · Dec 1, 2014 – Aug 10, 2023 · Past |
| John Peter Wolf III Other companies: Nabriva Therapeutics AG (General Counsel and Corp. Sec. · Dec 30, 2016 – Dec 30, 2016 · Past); Viropharma Inc (VP, General Counsel · Jun 10, 2013 – Jan 24, 2014 · Past) | General Counsel · Dec 10, 2014 – Dec 10, 2014 · Past |
| Carl N Kraus Other companies: Aquestive Therapeutics, Inc. (Chief Medical Officer · Since at least Jun 26, 2023) | CHIEF MEDICAL OFFICER · Sep 28, 2022 – Jan 20, 2023 · Past |
| Daniel Salain Other companies: CalciMedica, Inc. (CTOO · Sep 24, 2020 – Dec 8, 2020 · Past) | CHIEF OPERATING OFFICER · Sep 28, 2022 – Jan 20, 2023 · Past |
| Louis J Arcudi III Other companies: Tempest Therapeutics, Inc. (President and CEO, Director · Dec 7, 2018 – Feb 26, 2021 · Past) | Chief Financial Officer · Jan 3, 2017 – Aug 13, 2018 · Past |
| John Clayton Taylor | CHIEF EXECUTIVE OFFICER, Director · Sep 28, 2022 – Jan 20, 2023 · Past |
| Jonathan Michael Yingling | Chief Scientific Officer · Jul 9, 2019 – Jan 10, 2020 · Past |
All 12 people
| Person | Seat |
|---|---|
| Robert C Fletcher | Sr. VP, Bus. Dev. & Strategy · Jan 3, 2017 – Jul 21, 2020 · Past |
| Sudhir Agrawal | President of Research, Director · Jan 6, 2016 – Jan 3, 2017 · Past |
Log in to ask 6ix AI your own questions about Aceragen Inc.